Nightingale Health Oyj Class B

As of June 30, 2026, Nightingale Health Oyj Class B carries a market capitalization of 57.22M, placing it among publicly traded companies globally. Its enterprise value stands at 24.52M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Nightingale Health Oyj Class B's next confirmed earnings release is scheduled for March 9, 2027.

As of June 30, 2026, Nightingale Health Oyj Class B has 60.36M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Nightingale Health Oyj Class B maintains a current ratio of 6.37, meaning it holds 6.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Nightingale Health Oyj Class B's stock has declined approximately 47.20% over the past 52 weeks. The 50-day moving average sits at 1.01, while the 200-day moving average is 1.16.

As of June 30, 2026, Nightingale Health Oyj Class B holds 36.80M in cash and equivalents against 4.09M in total debt, resulting in a net debt position of -36.80M. Total book value stands at 48.74M, with working capital of 34.29M providing operational flexibility.